Literature DB >> 30721641

Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017.

Grace E Marx1,2, Yushiuan Chen1, Michele Askenazi1, Bernadette A Albanese1.   

Abstract

OBJECTIVES: In Colorado, legalization of recreational marijuana in 2014 increased public access to marijuana and might also have led to an increase in emergency department (ED) visits. We examined the validity of using syndromic surveillance data to detect marijuana-associated ED visits by comparing the performance of surveillance queries with physician-reviewed medical records.
METHODS: We developed queries of combinations of marijuana-specific International Classification of Diseases, Tenth Revision (ICD-10) diagnostic codes or keywords. We applied these queries to ED visit data submitted through the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE) syndromic surveillance system at 3 hospitals during 2016-2017. One physician reviewed the medical records of ED visits identified by ≥1 query and calculated the positive predictive value (PPV) of each query. We defined cases of acute adverse effects of marijuana (AAEM) as determined by the ED provider's clinical impression during the visit.
RESULTS: Of 44 942 total ED visits, ESSENCE queries detected 453 (1%) as potential AAEM cases; a review of 422 (93%) medical records identified 188 (45%) true AAEM cases. Queries using ICD-10 diagnostic codes or keywords in the triage note identified all true AAEM cases; PPV varied by hospital from 36% to 64%. Of the 188 true AAEM cases, 109 (58%) were among men and 178 (95%) reported intentional use of marijuana. Compared with noncases of AAEM, cases were significantly more likely to be among non-Colorado residents than among Colorado residents and were significantly more likely to report edible marijuana use rather than smoked marijuana use ( P < .001).
CONCLUSIONS: ICD-10 diagnostic codes and triage note keyword queries in ESSENCE, validated by medical record review, can be used to track ED visits for AAEM.

Entities:  

Keywords:  ICD-10; marijuana; surveillance; syndromic

Mesh:

Year:  2019        PMID: 30721641      PMCID: PMC6410484          DOI: 10.1177/0033354919826562

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  20 in total

Review 1.  A systems overview of the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE II).

Authors:  Joseph Lombardo; Howard Burkom; Eugene Elbert; Steven Magruder; Sheryl Happel Lewis; Wayne Loschen; James Sari; Carol Sniegoski; Richard Wojcik; Julie Pavlin
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

2.  Assessment of ESSENCE performance for influenza-like illness surveillance after an influenza outbreak--U.S. Air Force Academy, Colorado, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-04-08       Impact factor: 17.586

3.  Using Syndromic Surveillance for All-Hazards Public Health Surveillance: Successes, Challenges, and the Future.

Authors:  Paula W Yoon; Amy I Ising; Julia E Gunn
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

4.  Characterization of edible marijuana product exposures reported to United States poison centers.

Authors:  Dazhe Cao; Sahaphume Srisuma; Alvin C Bronstein; Christopher O Hoyte
Journal:  Clin Toxicol (Phila)       Date:  2016-07-15       Impact factor: 4.467

5.  Physician and coding errors in patient records.

Authors:  S S Lloyd; J P Rissing
Journal:  JAMA       Date:  1985-09-13       Impact factor: 56.272

6.  Validation of a Syndromic Case Definition for Detecting Emergency Department Visits Potentially Related to Marijuana.

Authors:  Kathryn DeYoung; Yushiuan Chen; Robert Beum; Michele Askenazi; Cali Zimmerman; Arthur J Davidson
Journal:  Public Health Rep       Date:  2017-06-06       Impact factor: 2.792

7.  Tasty THC: Promises and Challenges of Cannabis Edibles.

Authors:  Daniel G Barrus; Kristen L Capogrossi; Sheryl C Cates; Camille K Gourdet; Nicholas C Peiper; Scott P Novak; Timothy W Lefever; Jenny L Wiley
Journal:  Methods Rep RTI Press       Date:  2016-11

8.  Marijuana Tourism and Emergency Department Visits in Colorado.

Authors:  Howard S Kim; Katelyn E Hall; Emma K Genco; Mike Van Dyke; Elizabeth Barker; Andrew A Monte
Journal:  N Engl J Med       Date:  2016-02-25       Impact factor: 91.245

9.  The Public Health Framework of Legalized Marijuana in Colorado.

Authors:  Tista Ghosh; Mike Van Dyke; Ali Maffey; Elizabeth Whitley; Laura Gillim-Ross; Larry Wolk
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

10.  Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado.

Authors:  Katelyn E Hall; Andrew A Monte; Tae Chang; Jacob Fox; Cody Brevik; Daniel I Vigil; Mike Van Dyke; Katherine A James
Journal:  Acad Emerg Med       Date:  2018-04-10       Impact factor: 3.451

View more
  4 in total

1.  County-Level Recreational Marijuana Policies and Local Policy Changes in Colorado and Washington State (2012-2019).

Authors:  Denise D Payán; Paul Brown; Anna V Song
Journal:  Milbank Q       Date:  2021-08-18       Impact factor: 4.911

2.  How high: Differences in the developments of cannabis markets in two legalized states.

Authors:  Caislin L Firth; Steven Davenport; Rosanna Smart; Julia A Dilley
Journal:  Int J Drug Policy       Date:  2019-11-28

3.  Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE): Overview, Components, and Public Health Applications.

Authors:  Howard Burkom; Wayne Loschen; Richard Wojcik; Rekha Holtry; Monika Punjabi; Martina Siwek; Sheri Lewis
Journal:  JMIR Public Health Surveill       Date:  2021-06-21

4.  Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes.

Authors:  Eric E Kaczor; Bonnie Mathews; Kara LaBarge; Brittany P Chapman; Stephanie Carreiro
Journal:  J Med Toxicol       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.